Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

All hope is not lost for a reunion between the Minnesota Vikings and quarterback Sam Darnold. The post Vikings Get Good News ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating for Viking Holdings, raising the price target to $58 from $50.

The Minnesota Vikings are primed to franchise tag QB Sam Darnold and then trade him in an unprecedented NFL move.

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...

That was before quarterback guru Kevin O'Connell arrived in Minnesota. He's made the Vikings a dream destination for any ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking’s focus on educational experiences ... market share within the expanding global vacation market. Price Action: VIK shares are trading higher by 5.79% at $47.75 on the last check Friday.